Advertisement
Canada markets close in 5 hours 5 minutes
  • S&P/TSX

    21,930.82
    +45.44 (+0.21%)
     
  • S&P 500

    5,104.03
    +55.61 (+1.10%)
     
  • DOW

    38,212.03
    +126.23 (+0.33%)
     
  • CAD/USD

    0.7308
    -0.0015 (-0.21%)
     
  • CRUDE OIL

    83.47
    -0.10 (-0.12%)
     
  • Bitcoin CAD

    87,429.77
    +734.55 (+0.85%)
     
  • CMC Crypto 200

    1,338.43
    -58.10 (-4.15%)
     
  • GOLD FUTURES

    2,344.80
    +2.30 (+0.10%)
     
  • RUSSELL 2000

    2,000.26
    +19.14 (+0.97%)
     
  • 10-Yr Bond

    4.6570
    -0.0490 (-1.04%)
     
  • NASDAQ

    15,940.37
    +328.61 (+2.10%)
     
  • VOLATILITY

    15.30
    -0.07 (-0.46%)
     
  • FTSE

    8,139.11
    +60.25 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6839
    +0.0018 (+0.26%)
     

Will Clinical Trial Firm Icon Pass This Market Test?

Despite last week's sell-off on the Nasdaq and S&P 500, Ireland-based contract research organization (CRO) Icon has found support and shown resilience. Icon provides phase I - phase IV clinical trial services to pharmaceutical, biotech and medical device companies.